contrast, the incidence of SMA from patients with ,B-thalassaemia major and idiopathic thrombocytopenic purpura was no higher than in the controls. The discrepancy in incidence in haemolytic anaemias due to different causes may reflect the effect of endogenous and extrinsic agents. In the viral infections, SMA were mainly of the IgM class and gave an 'SMA-V' staining pattern. In bacterial infections (typhoid fever and brucellosis), SMA were either IgG only or IgM and IgG, and the staining pattern was also mainly 'SMA-V'. In infections which affect or may affect the liver (viral hepatitis, infectious mononucleosis, typhoid fever, and brucellosis), SMA was present at high titres (1:80-1:320), whereas in infections not affecting the liver (measles, mumps, and chickenpox) the titres were lower (<1:80). In most patients SMA occurred transiently and without apparent pathogenetic significance. The antigen against which infection-induced SMA is directed is not actin; its nature has yet to be identified.
Smooth muscle autoantibodies (SMA) are present in the sera of some patients with chronic active hepatitis (CAH) (Doniach et al., 1966; Johnson et al., 1965) , acute viral hepatitis (Farrow et al., 1970; Ajdukiewicz et al., 1972; Vittal et al., 1974; Kanakoudi et al., 1975) , infectious mononucleosis (Holborow et al., 1973; Sutton et al., 1974a) , cytomegalovirus (Andersen and Andersen, 1975) , Mycoplasma pneumoniae infections (Biberfeld and Sterner, 1976) , and malignant disease (Whitehouse and Holborow, 1971) . It has been suggested that high SMA titres (> 1/100) of the IgG class are of value in the diagnosis of CAH (Lidman et al., 1976) .
The nature of the antigen was first suspected by Farrow et al. (1971) , who showed that SMA reacted with actin-like microfilaments in cultured liver cells. They suggested that viral infection of liver cells Received for publication 25 May 1979 alters the submembranous microfilaments so that they become immunogenic. The antiactin specificity of SMA in CAH was subsequently confirmed by studies showing neutralisation of all antibody activity by absorption with actin from platelets or from skeletal muscle (Gabbiani et al., 1973; Andersen et al., 1976; Lidman et al., 1976; Kurki et al., 1978; Toh et al., 1978) . However, in diseases not involving the liver, the specificity of SMA has not been identified. Furthermore, other aspects of SMA require elucidation. First, does SMA occur in viral infections without liver involvement, or in bacterial infections which may affect the liver? Also, since some SMA are directed against actin, are these autoantibodies produced when actin is released from platelets or red cells, as in idiopathic thrombocytopenic purpura (ITP) and haemolytic anaemias? If so, are they autoimmune markers of nonimmunological disease or are they related to the In patients with viral hepatitis, infectious mononucleosis, measles, mumps, chickenpox, and typhoid fever, the first serum sample was taken between the seventh and 10th day of disease, and in brucellosis patients between the 10th and 15th day. A second sample was obtained seven to 10 days after the first. When the second sample was SMA positive, a third was obtained one to two months later. In the ITP group the first serum sample was obtained on the seventh to 30th day after the appearance of a haemorrhagic skin rash and before treatment. The second sample was taken seven to 10 days later and the third two to 24 months later. In the acute haemolytic anaemia group the first serum sample was taken on the second to sixth day after the onset of clinical symptoms and before blood transfusion. The second sample was taken five to seven days after blood transfusion and the third one to two months later. In the ,B-thalassaemia group serum samples were obtained 25 to 30 days after the last blood transfusion. Sera were coded and stored at -20°C.
DETECTION OF SMOOTH MUSCLE AUTOANTIBODIES
Autoantibodies were detected by immunofluorescence tests on sections (4,u) cut on a cryostat at -20°C, from unfixed composite tissue blocks of snap-frozen rat stomach, liver, and kidney. Fluorescein isothiocyanate labelled sheep anti-human immunoglobulin, IgM, and IgG (Wellcome Reagents) were used at suitable dilutions. Sera were heated at 56°C for 30 minutes and tested at a 1/10 dilution. Positive sera were titrated in doubling dilutions from 1/20 to 1/320 with all three conjugates. Samples positive at dilutions < 1:40 were recorded as doubtful (Fig. 1 ). All patients whose second or third serum sample was positive were recalled for examination six to 24 months after recovery. Reexamination included a detailed history, clinical examination, and detection and titration of serum SMA.
IMMUNOABSORPTION STUDIES
Fifty-six serum samples were absorbed with skeletal muscle actin or myosin by the method described 12)58 F. Kanakoudi-Tsakalidis, et al. previously by Toh et al. (1978) . Sera tested after absorption were from the following conditions: brucellosis (3), typhoid (3), 'G-6-PD deficiencyhaemolysis' (3), infectious mononucleosis (5) from viral hepatitis, measles, and typhoid), and a few gave apical staining of renal tubules. These three patterns conformed with the SMA-V, SMA-G, and SMA-T of Bottazzo et al. (1976) .
The SMA-V activity in 56 serum samples was not abolished by absorption with skeletal muscle actin or myosin.
LACK OF CORRELATION BETWEEN PRESENCE OF SMA AND CLINICAL AND LABORATORY FINDINGS
The results in relation to the main clinical and laboratory findings in patients during the acute stage of disease, and six months to two years later, are summarised as follows. In none of the diseases was the presence of SMA correlated with age or sex distribution of the patients. In addi- haemolytic anaemia due to G-6-PD deficiency (48%). By contrast, in fi-thalassaemia major and ITP, the incidence of SMA was not different from that in the controls (Table 2 ; Fig. 1 ). In chickenpox, although SMA was found in about half of the patients (9/19), the incidence was not significantly raised, but this may be due to the smaller number examined. These prevalence findings for SMA in viral hepatitis and infectious mononucleosis in children are similar to those reported for adults, viz, up to 81 % in viral hepatitis (Farrow et al., 1970; Ajdukiewicz et al., 1972; Vittal et al., 1974) and up to 75 % in infectious mononucleosis (Holborow et al., 1973; Sutton et al., 1974b) . The incidence of SMA in healthy adults, ranging from 12 % to 20% (Whitehouse and Holborow, 1971; Holborow et al., 1973; Sutton et al., 1974a; Shu etal., 1975) , is similar to that in a random population sample in Greece (19 4%). A higher incidence was observed in infancy and childhood (Papastavrou et al., 1979, unpublished data) . In the present study SMA was present in 20% of control children at titres of > 1:40 and in 25 % at lower titres ( < 1/20). Holborow et al. (1973) , however, found SMA in 10% of healthy children aged 10 years and under. The relatively higher incidence in the present study may be due to the wider age spectrum (infancy, pre-school age, school age, and puberty) and to the susceptibility of young infants to asymptomatic viral infections such as CMV and EBV. Another possible cause of the increased incidence of SMA in infancy may be vaccinations with live attenuated viruses which are usually performed at this early age.
The importance of extrinsic agents such as microorganisms rather than genetic factors in determining the presence and lack of sex selectivity of SMA was pointed out by Hooper et al. (1972) , who compared the incidence of SMA with that of other autoantibodies in an Australian population.
This concept is consistent with reports of a high incidence of SMA in patients with EBV, CMV, Mycoplasma pneumoniae infections, and warts (Sutton et al., 1974a; Andersen and Andersen, 1975; McMillan and Haire, 1975; Biberfeld and Sterner, 1976) , and the present findings accord with these. Particularly interesting is the contrast between acute haemolytic anaemia due to G-6-PD deficiency and ,B-thalassaemia major. In both conditions, destruction of cells rich in contractile proteins occurs, but an increased incidence of SMA was demonstrated only in patients with acute haemolytic anaemia. The rate of antigen release and its amount in the circulation may be important factors for the production of SMA, but involvement of exogenous agents (ie, drugs) in the haemolysis due to G-6-PD deficiency may as well account for this difference in the findings between the two haemolytic states. SMA production under these conditions may be an example of bypass of self-tolerance by extrinsic factors, due to either cross-antigenicity with self components (Wang et al., 1975) or to a 'hapten-carrier' mechanism (Allison et al., 1971) . The findings favour the concept that cell breakdown with release of antigens is alone insufficient to account for SMA production (Fairfax and Groschel-Stewart, 1977) .
A low prevalence of SMA was also demonstrated in ITP. The pathogenesis of this disease is not yet completely known. Classic concepts on the subject postulate that platelets react with an autoantibody and are eventually destroyed by macrophages, predominantly in the spleen (Rosse, 1978) . It is not known whether the platelets are modified so that contractile protein (thrombosthenin) becomes both accessible and immunogenic (as probably happens when hepatocytes are infected by virus) nor whether antigenic material is released after destruction of platelets by macrophages so that SMA production is triggered. So far, a role for an exogenous agent which might enhance SMA production in ITP has not been established. Until these questions are settled, the low incidence of SMA in ITP cannot be adequately accounted for. However, it is worth pointing out that only acute cases responsive to corticosteroids were included in this study. It might be interesting to study chronic, cortico-resistant cases of ITP undergoing splenectomy or immunosuppressive therapy.
Antiactin specificity of SMA has been demonstrated only in CAH (Gabbiani et al., 1973; Andersen et al., 1976; Lidman et al., 1976; Kurki et al., 1978; Toh et al., 1978) . The present study confirms previous reports that SMA from patients with non-liver diseases does not react with actin or myosin (Andersen et al., 1976; Bottazzo et al., 1976; Fairfax and Groschel-Stewart, 1977; Kurki et al., 1978) . Antiactin SMA in CAH is of the IgG class, persists in high titre (>1/100), and gives a mainly 'SMA-T' staining pattern (Bottazzo et al., 1976) . By contrast, SMA in viral infections is mainly IgM (Andersen and Andersen, 1975) , occurs transiently during the acute stage of disease, is present in low titres (< 1:80), and gives a mainly 'SMA-V' staining pattern (Bottazzo et al., 1976) .
Titres in viral hepatitis, infectious mononucleosis, typhoid fever, and brucellosis were high (1:80-1:320) in this study but lower in measles, mumps, and chickenpox (1:40-1:80) (Fig. 2) . In viral infections SMA was mainly IgM, in bacterial infections either IgG or IgM and IgG, and in all infections was mainly of the 'SMA-V' staining pattern. The presence of IgG SMA in patients with bacterial infections may be due to serum samples being obtained later in the disease than in the viral infections (Table 3 ). These findings suggest that SMA are produced in high titres mainly in infections which affect or may affect the liver (hepatitis, infectious mononucleosis, typhoid fever, and brucellosis). No relationship with other clinical or laboratory findings was observed.
The early appearance and short duration of smooth muscle autoantibodies in our patients' sera emphasises that they are transient and in this respect unlike other autoantibodies such as antinuclear antibody which are often persistent markers of autoimmune disease. The lack of correlation between the presence of SMA and the clinical and laboratory findings, either during the course of the disease or after recovery, suggests that SMA do not participate in immunopathogenic processes. In the small proportion of patients in whom SMA persisted for up to 1 years there was also no association with the course of the disease, in agreement with previous observations in viral hepatitis (Ajdukiewicz et al., 1972) and infectious mononucleosis (Holborow et al., 1973) patients.
